PMVP PMV Pharmaceuticals beats Q4 2025 EPS estimates by 177 percent shares hold steady in todays trading ORIC Oric Pharmaceuticals posts narrower than expected Q4 2025 loss shares rise 466 percent in todays trading ASML Holding NV ASML Upgraded to Buy Rating on Sustained Earnings Estimate Revisions Kinder Morgan Inc KMI Valuation Assessment Following 29 12Month Share Price Appreciation Zebra ZBRA Stock Fundamentals Zebra Posts 2 EPS Miss Trailing Street Estimates ConocoPhillips COP Sector Consolidation Catalyst as Shells 136B ARC Resources Acquisition Signals Upstream Value Upside GILT Gilat posts 435 percent Q4 2025 EPS upside sending shares 637 percent higher in daily trading CO2 Energy NOEMR Stock Downside Risk Evaluation